Minerva Neurosciences plans to price public offering of common shares

Bookrunner Jefferies conducts offering; lead manager JMP will assist

By Devika Patel

Knoxville, Tenn., June 13 – Minerva Neurosciences, Inc. will conduct a public sale of common stock with a 30-day greenshoe option, according to a prospectus supplement filed Monday with the Securities and Exchange Commission.

The company will sell 6 million shares, with an additional 900,000 shares as part of the greenshoe.

Jefferies is the bookrunner. JMP Securities is the lead manager.

Proceeds will be used for clinical development, working capital and general corporate purposes.

The clinical-stage biopharmaceutical company is based in Cambridge, Mass.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.